Agentix (AGTX) Exchange Rate Effect (2022 - 2026)
Agentix's (AGTX) quarterly Exchange Rate Effect came in at -$20401.0 in Q1 2026, down 255.54% YoY from $13116.1 in Q1 2025, and down 1392.39% on a QoQ basis from -$1367.0 in Q4 2025.
Agentix (AGTX) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Agentix (AGTX) has 5 years of Exchange Rate Effect data on file, last reported at -$20401.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 255.54% year-over-year to -$20401.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5627.0 (down 124.44% YoY) and the FY2026 annual result came in at -$5627.0, down 124.44% from the prior year.
- Exchange Rate Effect retreated to -$20401.0 in Q1 2026, from -$1367.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $63927.0 in Q4 2024 to a low of -$36889.0 in Q4 2023.
- A 5-year average of $2125.2 and a median of -$1766.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect tumbled 1557.93% — and 2024, when it surged 777.99%.
- Tracing AGTX's Exchange Rate Effect over 5 years: stood at -$2225.0 in 2022, then plunged by 1557.93% to -$36889.0 in 2023, then soared by 273.3% to $63927.0 in 2024, then tumbled by 102.14% to -$1367.0 in 2025, then tumbled by 1392.39% to -$20401.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$20401.0 (Q1 2026), -$1367.0 (Q4 2025), and -$2165.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | -611.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -611.00 |
| Jun 30, 2026 | -611.00 |
| Mar 31, 2026 | -20,401.00 |
| Mar 31, 2026 | -20,401.00 |
| Dec 31, 2025 | -1,367.00 |
| Dec 31, 2025 | -1,367.00 |
| Sep 30, 2025 | -2,165.00 |
| Sep 30, 2025 | -2,165.00 |
| Jun 30, 2025 | 18,306.00 |
| Jun 30, 2025 | 18,306.00 |
| Mar 31, 2025 | -5,738.00 |
| Mar 31, 2025 | -5,738.00 |
| Dec 31, 2024 | 63,927.00 |
| Dec 31, 2024 | 63,927.00 |
| Sep 30, 2024 | -20,106.00 |
| Sep 30, 2024 | -20,106.00 |
| Jun 30, 2024 | -15,063.00 |
| Jun 30, 2024 | -15,063.00 |
| Mar 31, 2024 | 26,252.00 |
| Mar 31, 2024 | 26,252.00 |